CFB and pulmonary arterial hypertension: We found that compared with baseline, administration of GnRHa plus rhGH led to a more significant increase in height, PAH and HtSDS-BA, corresponding to a WMD (95% CI) of 10.38 cm (8.60–12.17), 6.94 cm (5.34–8.54), and 0.92 (0.68–1.17) respectively.